<DOC>
	<DOC>NCT00537901</DOC>
	<brief_summary>First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum</brief_summary>
	<brief_title>First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Patients with metastatic cancer of colon or rectum</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Colon and Rectum Cancer</keyword>
</DOC>